Inmaculada Rodríguez

2.2k total citations
24 papers, 1.5k citations indexed

About

Inmaculada Rodríguez is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Inmaculada Rodríguez has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 17 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Inmaculada Rodríguez's work include Immunotherapy and Immune Responses (17 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immune Cell Function and Interaction (9 papers). Inmaculada Rodríguez is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immune Cell Function and Interaction (9 papers). Inmaculada Rodríguez collaborates with scholars based in Spain, United States and United Kingdom. Inmaculada Rodríguez's co-authors include Ignacio Melero, María E. Rodríguez-Ruiz, José Luis Perez‐Gracia, Miguel F. Sanmamed, Saray Garasa, Arantza Azpilikueta, Pedro Berraondo, Elixabet Bolaños, Sara Labiano and María C. Ochoa and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Inmaculada Rodríguez

24 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inmaculada Rodríguez Spain 19 1.0k 991 285 121 118 24 1.5k
Lukasz K. Chlewicki United States 10 987 1.0× 1.3k 1.3× 315 1.1× 205 1.7× 73 0.6× 15 1.7k
Elixabet Bolaños Spain 19 887 0.9× 972 1.0× 290 1.0× 80 0.7× 146 1.2× 33 1.4k
Sara Labiano Spain 20 1.4k 1.4× 1.5k 1.5× 398 1.4× 84 0.7× 166 1.4× 41 2.1k
Arantza Azpilikueta Spain 26 1.6k 1.5× 1.8k 1.8× 438 1.5× 118 1.0× 180 1.5× 47 2.4k
Michelle M. Langhan United States 8 1.6k 1.6× 1.3k 1.3× 344 1.2× 81 0.7× 291 2.5× 10 1.9k
Aniruddha Choudhury Sweden 20 909 0.9× 1.2k 1.2× 460 1.6× 185 1.5× 96 0.8× 38 1.7k
Willemijn Hobo Netherlands 26 1.3k 1.3× 1.5k 1.5× 520 1.8× 138 1.1× 79 0.7× 50 2.2k
Sylvie Rusakiewicz France 22 800 0.8× 800 0.8× 322 1.1× 98 0.8× 39 0.3× 44 1.4k
Gustav Ullenhag Sweden 24 1.1k 1.1× 837 0.8× 633 2.2× 149 1.2× 291 2.5× 97 1.8k
Kalijn F. Bol Netherlands 21 1.1k 1.0× 1.3k 1.3× 523 1.8× 62 0.5× 79 0.7× 42 1.7k

Countries citing papers authored by Inmaculada Rodríguez

Since Specialization
Citations

This map shows the geographic impact of Inmaculada Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inmaculada Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inmaculada Rodríguez more than expected).

Fields of papers citing papers by Inmaculada Rodríguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inmaculada Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inmaculada Rodríguez. The network helps show where Inmaculada Rodríguez may publish in the future.

Co-authorship network of co-authors of Inmaculada Rodríguez

This figure shows the co-authorship network connecting the top 25 collaborators of Inmaculada Rodríguez. A scholar is included among the top collaborators of Inmaculada Rodríguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inmaculada Rodríguez. Inmaculada Rodríguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cirella, Assunta, Myriam Fernández-Sendin, Inmaculada Rodríguez, et al.. (2022). Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis. OncoImmunology. 11(1). 2098657–2098657. 2 indexed citations
2.
Teijeira, Álvaro, Saray Garasa, Carlos Luri‐Rey, et al.. (2022). Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy. Cancer Research. 82(23). 4373–4385. 22 indexed citations
3.
Rodríguez‐Carrio, Javier, Inmaculada Rodríguez, Marta Pevida, et al.. (2021). Distinct profiles of immune cell populations underlie in-stent restenosis: a cluster analysis approach. European Heart Journal. 42(Supplement_1). 2 indexed citations
4.
Rodríguez-Ruiz, María E., Inmaculada Rodríguez, Tania Labiano, et al.. (2019). TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies. Molecular Cancer Therapeutics. 18(3). 621–631. 71 indexed citations
5.
Aznar, M. Ángela, Carmen Molina, Álvaro Teijeira, et al.. (2019). Repurposing the yellow fever vaccine for intratumoral immunotherapy. EMBO Molecular Medicine. 12(1). e10375–e10375. 32 indexed citations
6.
Aznar, M. Ángela, Lourdes Planelles, Carmen Molina, et al.. (2019). Immunotherapeutic effects of intratumoral nanoplexed poly I:C. Journal for ImmunoTherapy of Cancer. 7(1). 116–116. 103 indexed citations
7.
Rodríguez-Ruiz, María E., Inmaculada Rodríguez, Fernando López‐Campos, et al.. (2018). Immune mechanisms mediating abscopal effects in radioimmunotherapy. Pharmacology & Therapeutics. 196. 195–203. 55 indexed citations
8.
Rodríguez-Ruiz, María E., José Luis Perez‐Gracia, Inmaculada Rodríguez, et al.. (2018). Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients. Annals of Oncology. 29(5). 1312–1319. 114 indexed citations
9.
Rodríguez, Javier, Eduardo Castañón, José Luis Perez‐Gracia, et al.. (2018). A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis. Journal for ImmunoTherapy of Cancer. 6(1). 96–96. 39 indexed citations
10.
Ochoa, María C., Luna Minute, Elísabeth Pérez-Ruiz, et al.. (2017). Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15. OncoImmunology. 7(2). e1393597–e1393597. 22 indexed citations
11.
Rodríguez-Ruiz, María E., Inmaculada Rodríguez, Benigno Barbés, et al.. (2017). Brachytherapy attains abscopal effects when combined with immunostimulatory monoclonal antibodies. Brachytherapy. 16(6). 1246–1251. 35 indexed citations
12.
Ochoa, María C., Luna Minute, Inmaculada Rodríguez, et al.. (2017). Antibody‐dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells. Immunology and Cell Biology. 95(4). 347–355. 162 indexed citations
13.
Rodríguez-Ruiz, María E., Inmaculada Rodríguez, Saray Garasa, et al.. (2016). Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming. Cancer Research. 76(20). 5994–6005. 198 indexed citations
14.
Rodríguez-Ruiz, María E., Saray Garasa, Inmaculada Rodríguez, et al.. (2016). Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule Are Induced by Ionizing Radiation on Lymphatic Endothelium. International Journal of Radiation Oncology*Biology*Physics. 97(2). 389–400. 52 indexed citations
15.
Sanmamed, Miguel F., Inmaculada Rodríguez, Kurt A. Schalper, et al.. (2015). Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2−/−IL2Rγnull Immunodeficient Mice. Cancer Research. 75(17). 3466–3478. 129 indexed citations
16.
Quetglas, José I., Sara Labiano, M. Ángela Aznar, et al.. (2015). Virotherapy with a Semliki Forest Virus–Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade. Cancer Immunology Research. 3(5). 449–454. 89 indexed citations
17.
Sanmamed, Miguel F., Carlos Alfaro, Carmen Oñate, et al.. (2014). Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins. Clinical Cancer Research. 20(22). 5697–5707. 204 indexed citations
18.
Morales‐Kastresana, Aizea, Miguel F. Sanmamed, Inmaculada Rodríguez, et al.. (2013). Combined Immunostimulatory Monoclonal Antibodies Extend Survival in an Aggressive Transgenic Hepatocellular Carcinoma Mouse Model. Clinical Cancer Research. 19(22). 6151–6162. 81 indexed citations
19.
Ochoa, María C., Jessica Fioravanti, Inmaculada Rodríguez, et al.. (2012). Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein. Cancer Research. 73(1). 139–149. 39 indexed citations
20.
Alfaro, Carlos, Natalia Suárez, Carmen Oñate, et al.. (2011). Dendritic Cells Take up and Present Antigens from Viable and Apoptotic Polymorphonuclear Leukocytes. PLoS ONE. 6(12). e29300–e29300. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lukasz K. Chlewicki Breakdown of academic impact, for papers by Elixabet Bolaños Breakdown of academic impact, for papers by Sara Labiano Breakdown of academic impact, for papers by Arantza Azpilikueta Breakdown of academic impact, for papers by Michelle M. Langhan Breakdown of academic impact, for papers by Aniruddha Choudhury Breakdown of academic impact, for papers by Willemijn Hobo Breakdown of academic impact, for papers by Sylvie Rusakiewicz Breakdown of academic impact, for papers by Gustav Ullenhag Breakdown of academic impact, for papers by Kalijn F. Bol
Rankless by CCL
2026